Descrizione del progetto
Una piattaforma di sanità elettronica per la diagnostica e la terapia dei disturbi gastrointestinali
Il progetto eCAP, finanziato dall’UE, si propone di creare un innovativo dispositivo medico che combini una capsula intelligente con una piattaforma di sanità elettronica per la diagnostica, la gestione delle malattie e il miglioramento degli esiti clinici dei pazienti affetti da patologie gastrointestinali. Il progetto creerà una capsula impiantabile modulare dotata di una capacità di multi-rilevamento per il monitoraggio della fisiologia gastrointestinale. eCAP si avvarrà della comunicazione tramite smartphone, congiuntamente alla tecnologia di cloud computing e a interfacce applicative, allo scopo di integrare, elaborare e interpretare i dati fisiologici longitudinali raccolti dalla capsula. I test personalizzati forniranno risultati accurati a partire dai dati in entrata a flusso molteplice, con un’interpretazione assistita dall’IA. L’ambizioso obiettivo è quello di facilitare la transizione nel campo della diagnostica gastrointestinale verso un approccio di sanità elettronica incentrato sui pazienti e dispositivi medici connessi per il loro monitoraggio a distanza.
Obiettivo
eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics, patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our project will create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlled time period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitous smartphone communication standard, together with cloud computing technology and application interfaces to integrate, process and interpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinical usefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the test for the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by Artificial Intelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctors worldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings using gastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluation with health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developed to train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantable capsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue version to a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remote patient monitoring.
Campo scientifico
- natural sciencescomputer and information sciencesartificial intelligence
- medical and health scienceshealth scienceshealth care serviceseHealth
- medical and health sciencesbasic medicinephysiology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- medical and health sciencesclinical medicinegastroenterology
Parole chiave
Programma(i)
Meccanismo di finanziamento
HORIZON-IA - HORIZON Innovation ActionsCoordinatore
67000 Strasbourg
Francia